AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
A legfontosabb adatok
- Ki végzi
- Shanghai Jiao Tong University Affiliated Sixth People's Hospital
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 10 000 fő, tervezett
- Kezdés
- 2025. jan. 10.
- Várható befejezés
- 2027. jún. 30.
- A vizsgálat típusa
- Megfigyeléses, 4 csoport
- A regiszteradat frissítve
- 2025. június 3.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults who have, or may have, a brain aneurysm (a bulge in a brain blood vessel) and are having a head MRA or head/neck CTA scan. It tests AI software that finds aneurysms and predicts growth or rupture.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- A first diagnosis or symptoms that point to a possible brain aneurysm.
- Korábbi kezelés
- People who have had treatment inside the brain arteries before, such as a stent or partial aneurysm coil treatment, cannot join.
A részvétel fő kizáró okai
- Other brain blood vessel diseases, such as moyamoya disease, arteriovenous malformations, arteriovenous fistulas, blocked arteries or artery tears
- Severe allergy to contrast dye or strong reasons not to receive iodine contrast (CTA part only)
- Weak kidneys with serum creatinine more than twice the upper normal limit (CTA part only)
- Reasons not to have an MRI, such as a pacemaker or fear of closed spaces (MRA part only)
- Mental health, memory or emotional problems that prevent finishing the study, or conditions that spoil scan quality
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥ 18 years
- Preliminary diagnosis or symptoms indicating the presence or potential presence of a cerebral aneurysm
- Undergoing a non-contrast head MRA or contrast-enhanced head/neck CTA
- The patient or their legal representative is able and willing to sign an informed consent form
Ki nem vehet részt
- Other intracranial vascular diseases: moyamoya disease, arteriovenous malformations, arteriovenous fistulas, arterial occlusions, and arterial dissections
- History of intracranial arterial interventions: stent placement, partial aneurysm coil treatment, etc
- Severe allergy to contrast agents or absolute contraindications to iodine-based contrast agents
- Diseases or conditions that affect the quality of CTA/MRA images
- Inability to complete the study due to psychiatric disorders, cognitive, or emotional disturbances; Note: The CTA sub-study does not include exclusion criterion 5; the MRA sub-study does not include exclusion criteria 3 and 4
- Renal insufficiency with elevated serum creatinine (greater than twice the upper normal limit)
- MRI contraindications: pacemakers, claustrophobia, etc
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Aneurysmal subarachnoid hemorrhage (SAH) is one of the critical diseases that severely threaten human health, with a clinical mortality rate reaching as high as 30%. Early diagnosis and intervention before rupture are considered key to improving the prognosis of aneurysmal SAH. With the widespread clinical application of non-invasive cerebrovascular imaging techniques, such as CTA and MRA, the detection rate of unruptured intracranial aneurysms (UIAs) has significantly increased. However, addressing the growing demand for clinical cerebrovascular imaging diagnostics raises the challenge of improving diagnostic accuracy while alleviating the workload of diagnostic physicians. Furthermore, considering that not all detected UIAs will rupture, it is crucial to accurately identify high-risk aneurysms prone to rupture to avoid unnecessary overtreatment, which could lead to significant socioeconomic burdens and iatrogenic harm to patients.To meet this clinical need, researchers have developed an artificial intelligence (AI) algorithm to create software capable of automatically identifying intracranial aneurysms based on non-invasive vascular imaging data, enabling accurate diagnosis of aneurysms. To evaluate the clinical utility of this AI algorithm, a prospective, multicenter, registry study was proposed. Through long-term standardized and uniform non-invasive imaging follow-up, individualized imaging analysis profiles will be established. By correlating these profiles with aneurysm outcome events (growth or rupture), imaging features capable of accurately predicting aneurysm growth and rupture will be identified and analyzed. This approach is expected to enhance the accuracy of UIA diagnosis and enable risk stratification for unruptured intracranial aneurysms through the utilization of relevant data.
A vizsgálat 4 csoportja
- Single MRA
The patient has undergone an MRA examination only once.
- Multiple MRIs for one patient
The same patient underwent multiple MRAs.
- MRA+DSA
The patient underwent both MRA and DSA within three months.
- MRA+CTA
The patient underwent both MRA and CTA within three months.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Artificial Intelligence Applications for Cerebral Aneurysms Segmentation, Detection and Stability Prediction: a Stepwise, Multicenter Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. június 3.